Oral ivermectin for the treatment and prophylaxis of scabies in prison

Journal of Dermatological Treatment

Volumn 16, Issue 3, 2005, Pages 138-141

  De Andrade Quintanilha Ribeiro, Fernando ^a   Taciro, Edson ^a   Guerra, Marília Ribeiro M ^a   Eckley, Claudia A ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Apt 82 ^*  (Brazil)

Author keywords

Humans; Ivermectin; Prophylaxis; Scabies

Indexed keywords

IVERMECTIN;

ARTICLE; CONTROLLED STUDY; DISINFECTION; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRISON; PROPHYLAXIS; SARCOPTES SCABIEI; SCABIES; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTIPARASITIC AGENTS; BRAZIL; DISINFECTION; HUMANS; IVERMECTIN; MALE; PRISONERS; SCABIES; TREATMENT OUTCOME;

EID: 25444512177     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630510041277     Document Type: Article

References (32)

1. Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis. 2002;35:S146-S151.
2. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol. 1993;12:26-33.
3. Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol. 2000;143:520-3.
4. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health. 2000;31:147-51.
5. Walker CJA, Johnstone PW. A systematic review of treatment of scabies. Arch Dermatol. 2000;136:387-9.
6. Bouchard O, Houze S, Schiemann R, Durand R, Ralaimazava P, Ruggeri C, et al. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis. 2000;31:493-8.
7. Burkhart CN. Ivermectin: a few caveats are warranted before initiating therapy for scabies. Arch Dermatol. 1999;135:1549-50.
8. Cabrera H, Pietro PN, Argo G. Tratamiento de miasis superficial con Ivermectina. Act Tera Dermatol. 1998;21:370-2.
9. Cavalcanti TTB, Marques D, Melo MS, et al. Sarna, opção de tratamento por via oral. Jornal Brasileiro de Medicina. 2000;79:98-106.
10. Cestari SCP, Petri V, Rotta O, Alchorne MMA. Oral treatment of crusted scabies with ivermectin: report of two cases. Pediatr Dermatol. 2000;17:388-92.
11. Burkhart KM, Burkhart CN, Burkhart CG. Our scabies treatment is archaic, but ivermectin has arrived (Letter). Int J Dermatol. 1998;37:76-7.
12. Larralde M, Mijelsohn LM, Gonzales A, Mora E, Constantakos N. Ivermectin-responsive crusted scabies in four patients. Pediatr Dermatol. 1999;16:69-70.
13. Macdonald PJ, Chan C, Dickson J, Jean-Louis F, Heath A. Ophthalmomyiasis and nasal myiasis in New Zealand: a case series. N Z Med J. 1999;112:445-7.
14. Dourmishev A, Serafimova D, Dourmishev L, Mualla MA, Papaharalambous V, Malchevsky T. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin. Int J Dermatol. 1998;37:231-4.
15. Hergazy AA, Darwish NM, Abdel-Hamid IA, Hammad SM. Epidemiology and control of scabies in an Egyptian village. Int J Dermatol. 1999;38:291-5.
16. Kar SK, Mania J, Patnaik S. The use of ivermectin for scabies. Natl Med J India. 1994;7:15-16.
17. Martin-Prevel Y, Consnefroy JI, Tshipamba AP, Ngari P, Chodakewitz JA, Finder M. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg. 1993;48:186-92.
18. Marty P, Gari-Toussant LE, Fichoux Y. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann Trop Med Parasitol. 1994;88:453.
19. Offidani A, Cellini A, Simonetti O, Fumelli C. Treatment of scabies with ivermectin. Eur J Dermatol. 1999;9:100-1.
20. Chouela EN, Abeldano AM, Pellerano G, La Forgia M, Papale RM, Garsd A, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol. 1999;135:651-5.
21. Conti Diaz IA, Amaro J. Treatment of human scabies with oral ivermectin. Rev Inst Med Trop Sao Paulo. 1999;41:259-61.
22. Dourmishev A, Serafimova D, Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol. 1998;11:247-51.
23. Jaramillo-Ayerb F, Berrio-Munoz J. Ivermectin for crusted Norwegian scabies induced by use of topical steroids. Arch Dermatol. 1998;134:143-5.
24. Meinking LT, Taplin D, Hermida L, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med. 1995;333:26-30.
25. Taplin D, Meinking TL. Treatment of HIV-related scabies with emphasis on efficacy of ivermectin. Semin Cutan Med Surg. 1997;16:235-40.
26. Del Giudice P, Marty P. Editorial: Ivermectin a new therapeutic weapon in dermatology? Arch Dermatol. 1999;135:705-6.
27. Macotela RE, Pena-Gonzalez G. Tratamiento de la escabiasis com ivermectina por via oral. Gac Med Mex. 1993;129:201-5.
28. Nogueira MSQ, Dalligna SH, Franca C, Andrade A. Sarna crostosa em paciente HIV-1 positivo, apresentação de um caso. Ann Bras Dermatol RJ. 2000;75:29.
29. Chippaux JP, Bouchite M, Boussinesq M, Ranque S, Baldet T, Demanou M. Impact of repeated large scale ivermectin treatments on the transmission of Loa-loa. R Soc Trop Med Hyg. 1998;92:454-8.
30. Macotela RE, Mendez ICC, Nochebuena RE. Tratamiento de escabiasis com Ivermectina por via oral en una comunidad rural cerrada.Implicaciones epidemiologicas. Rev Mex Dermatol. 1996;40:179-84.
31. Cordoliani F, Vasseur E, Baccard M, Fournier S, Feuilhade de Chauvin M, Tancrede E, et al. Ivermectin-responsive crusted scabies in HTLV1 carrier. Dermatology. 1996;192:351-2.
32. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Aust J Dermatol. 1997;38:137-40.